首頁 > 市場調查報告書 > 醫療設備

呼吸器

市場調查報告書

商品編碼

1917926

體外膜氧合（ECMO）設備市場－2026-2031年預測

Extracorporeal Membrane Oxygenation Machine Market - Forecast from 2026 to 2031

出版日期: 2026年01月09日 | 出版商:

Knowledge Sourcing Intelligence | 英文 150 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

體外膜氧合（ECMO）設備市場預計將從 2025 年的 524,986,000 美元成長到 2031 年的 713,548,000 美元，複合年成長率為 5.25%。

體外膜氧合（ECMO）設備市場在為器官衰竭且常規治療方法無效的患者提供高級心肺生命支持方面發揮著至關重要的作用。這項先進技術由幫浦、氧合器和插管組成，可暫時取代心臟和/或肺部的功能，從而促進器官恢復。 ECMO 最初是為新生兒護理而開發的，其應用範圍已顯著擴大，涵蓋了患有嚴重心源性休克、急性呼吸窘迫症候群（ARDS）和體外心肺復甦術（ECPR）的重症成人和兒童患者。該市場的特點是設備安裝在三級醫療機構和大學附屬醫院，需要大量的資金投入、專業的臨床技術以及嚴格的法律規範。

主要市場促進因素與挑戰

市場成長的主要驅動力是全球範圍內嚴重心臟疾病和呼吸系統疾病盛行率的不斷上升。急性呼吸窘迫症候群（ARDS）和心源性休克等疾病發生率的增加直接擴大了需要高階支持的患者群體。由於傳統機械通氣可能會加重肺損傷，靜脈-靜脈（VV）體外膜氧合（ECMO）作為一種肺部保護策略，推動了對這類專用系統的需求。同樣，心血管疾病負擔的加重也推動了靜脈-動脈（VA）ECMO的需求，迫使醫院系統提升其ECMO能力。

技術進步是第二大成長要素。核心零件的持續創新，特別是高效聚甲基戊烯氧合器和低溶血磁浮離心式幫浦的研發，提高了治療的安全性和持續時間。這些改進推動了重症監護中心設備的升級和更新。一個關鍵機會在於日益小型化的攜帶式氧合（ECMO）系統的研發，這些系統正在拓展其臨床應用範圍，從ICU內支持擴展到院間轉運和院前急救，從而催生了來自急救醫療服務等新興客戶群的需求。

然而，市場面臨一個重大限制：治療總成本高昂。體外主機、一次性迴路以及需要專業人員長期入住加護病房等相關費用高昂，阻礙了ECMO的廣泛應用。這一成本障礙抑制了預算敏感型醫療系統的需求，並限制了市場滲透率，尤其是在發展中地區和資源匱乏的環境中。

市場區隔與競爭格局

市場區隔按治療方法和最終用戶分類。靜脈-靜脈（VV）體外膜氧合（ECMO）領域是一個主要的成長點，這主要得益於全球嚴重急性呼吸窘迫症候群（ARDS）的流行以及肺部休息療法的臨床應用。醫院，尤其是三級醫療機構和教學醫院，是主要的最終使用者群體。這些機構擁有必要的多學科團隊和基礎設施，並且通常被指定為區域ECMO轉診中心，因此需要持續投資於設備和耗材。

競爭格局高度集中，主要由在心肺技術領域擁有長期專業知識的跨國公司主導。主要企業包括美敦力公司（Medtronic plc）、利瓦諾瓦公司（LivaNova）和吉廷格公司（Getinge AB）。競爭的核心在於生物相容性、系統便攜性和先進監測功能整合等領域的技術差異化。一次性氧合器和泵浦迴路的可靠性和成本是重要的競爭領域，也是穩定的高收入來源。各公司正透過併購等策略活動來整合產品組合並鞏固市場地位。

區域展望

北美保持著市場主導地位，其特點是積極率先採用最尖端科技、擁有高度發達的重症監護基礎設施以及有利的報銷環境。歐洲緊隨其後，這得益於其強大且分散的醫療保健體系和高標準的臨床護理。亞太地區，尤其是中國，由於其龐大的患者群體、政府主導的醫療保健現代化以及諸如促進ECMO設備國產化以減少對進口依賴等戰略舉措，正迅速成為一個快速擴張的市場。在其他地區，例如中東，政府對專業重症監護中心的投資正在推動市場成長，但公立和私立醫療保健體系之間的市場動態存在顯著差異。

本報告的主要優勢：

深入分析：提供對主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
競爭格局：了解全球主要企業的策略舉措，並了解透過正確的策略進入市場的可能性。
市場促進因素與未來趨勢：探討影響市場的動態因素和關鍵趨勢及其對未來市場發展的影響。
可操作的建議：利用這些見解，在快速變化的環境中製定策略決策，發展新的商業機會和收入來源。
受眾廣泛：對Start-Ups、研究機構、顧問公司、中小企業和大型企業都很有用且經濟實惠。

本報告的使用範例

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

2021年至2025年的歷史數據和2026年至2031年的預測數據
成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
競爭定位、策略和市場佔有率分析
按業務板塊和地區（包括國家）分類的收入和預測評估
公司概況（策略、產品、財務資訊、關鍵發展等）

The Extracorporeal Membrane Oxygenation (ECMO) machine market is defined by its critical role in providing advanced cardiac and respiratory life support for patients with organ failure refractory to conventional therapies. This sophisticated technology, comprising a circuit with a pump, oxygenator, and cannulas, temporarily assumes the function of the heart and/or lungs, facilitating organ recovery. Initially developed for neonatal care, its application has expanded significantly to include adult and pediatric populations suffering from severe conditions such as refractory cardiogenic shock, Acute Respiratory Distress Syndrome (ARDS), and during extracorporeal cardiopulmonary resuscitation (ECPR). The market is characterized by its placement within tertiary care and academic medical centers, necessitating substantial capital investment, specialized clinical expertise, and operating under stringent regulatory oversight.

Primary Market Drivers and Challenges

Market growth is primarily driven by the increasing global prevalence of severe cardiac and respiratory diseases. The rising incidence of conditions like ARDS and cardiogenic shock directly expands the patient pool requiring advanced support. As conventional mechanical ventilation can exacerbate lung injury, Veno-Venous (VV) ECMO serves as a lung-protective strategy, thereby driving demand for these specialized systems. Similarly, the growing burden of cardiovascular diseases fuels the need for Veno-Arterial (VA) ECMO, compelling hospital systems to enhance their ECMO capabilities.

Technological advancements constitute a second major growth catalyst. Continuous innovation in core components, particularly the development of high-efficiency polymethylpentene oxygenators and less-hemolytic magnetic levitation centrifugal pumps, improves therapy safety and duration. These enhancements stimulate upgrades and replacements within critical care centers. A significant opportunity lies in the ongoing miniaturization and development of portable ECMO systems, which broaden clinical applications from in-ICU support to inter-hospital transport and pre-hospital care, thereby generating demand from new customer segments like emergency medical services.

However, the market faces a significant constraint in the exorbitant total cost of care. The high expense of the ECMO console, single-use disposable circuits, and the requisite prolonged ICU stay with specialized staff limits broader adoption. This cost barrier suppresses demand in budget-sensitive healthcare systems and restricts market penetration, particularly in developing regions and low-resource settings.

Market Segments and Competitive Landscape

The market is segmented by modality and end-user. The Veno-Venous (VV) ECMO segment is a key growth area, driven by the global prevalence of severe ARDS and the clinical adoption of lung-rest strategies. Hospitals, specifically tertiary care and academic medical centers, represent the dominant end-user segment. These institutions possess the necessary multidisciplinary teams and infrastructure, and are often designated as regional ECMO referral centers, mandating continuous investment in both equipment and disposable components.

The competitive environment is consolidated, dominated by multinational corporations that leverage long-standing expertise in cardiopulmonary technology. Key players include Medtronic plc, LivaNova, and Getinge AB. Competition centers on technological differentiation in areas such as biocompatibility, system portability, and the integration of advanced monitoring features. The reliability and cost of disposable oxygenator and pump circuits represent a consistent, high-volume revenue stream and a critical competitive battleground. Strategic activities, including mergers and acquisitions, are employed to consolidate portfolios and enhance market position.

Geographical Outlook

North America maintains market dominance, characterized by aggressive early adoption of cutting-edge technology, a highly developed critical care infrastructure, and a favorable reimbursement landscape. Europe follows with a robust, decentralized healthcare system and high standards of clinical care. The Asia-Pacific region, particularly China, represents a rapidly expanding market driven by immense patient volume, government-led healthcare modernization, and a strategic push toward domestic manufacturing of ECMO devices to reduce import reliance. Other regions, such as the Middle East, show growth driven by governmental investment in specialized critical care centers, though market dynamics vary significantly between public and private healthcare systems.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Segmentation

By Product
ECMO Machine
Software
By Component
Pumps
Oxygenators
Cannul
Accessories
By Modality Outlook
Veno-Venous
Veno-Arterials
Arterio-Venous
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET BY PRODUCT

5.1. Introduction
5.2. ECMO Machine
5.3. Software

6. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET BY COMPONENT

6.1. Introduction
6.2. Pumps
6.3. Oxygenators
6.4. Cannul
6.5. Accessories

7. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET BY MODALITY OUTLOOK

7.1. Introduction
7.2. Veno-Venous
7.3. Veno-Arterials
7.4. Arterio-Venous

8. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others